-
to understand tumor microenvironment, discover novel targets, and develop therapeutic strategies for targeting aggressive brain metastatic cancers, including breast, non-small, and small cell lung cancers
-
-derived xenograft mouse glioma models. His current focus is on engineering nanoparticles for more targeted laser therapeutics and exploring new drug discovery for pediatric high-grade gliomas using
-
patient-derived xenograft (PDX) models to discover novel therapeutic targets and biomarkers. The postdoc will have access to state-of-the-art facilities, multidisciplinary collaborations, and opportunities
-
on engineering nanoparticles for more targeted laser therapeutics and exploring new drug discovery for pediatric high-grade gliomas using connectivity mapping. Additionally, we are actively involved in
-
, CRISPR-based functional genomic screening, and patient-derived xenograft (PDX) models to discover novel therapeutic targets and biomarkers. The postdoc will have access to state-of-the-art facilities
-
to identify the key tumorigenic pathways/drivers, and target these for cancer therapeutics using in vitro and in vivo pharmaco-genetic approaches. The special focus is on medulloblastoma (a pediatric
-
of various psychopathologies and the target engagement by various intervention modalities. Clinical study design, neuroimaging study design, data collection, data analysis, and interpretation of data
-
neuroscience, with demonstrated success as a recent Ph.D. graduate with a track record in (1) statistical modeling, (2) tobacco regulatory science, or (3) neurocognition and brain development. The successful
-
for data visualization and presentation. A track record of first-author publications in peer-reviewed journals. Experience in conducting bench or human studies is preferred. Application Information
-
neurobiology in the context of neuropathogenesis and inflammation. Proficiency in advanced molecular and cellular techniques, along with experience in neurobiology and a proven track record of scientific